Derosa, Giuseppe

Fogari, Roberto

Mugellini, Amedeo

Preti, Paola

Zoppi, Annalisa

English

PubMed

R. Fogari

PRETI, PAOLA STEFANIA

A. Zoppi

G. Derosa

MUGELLINI, AMEDEO

Archivio Istituzionale della Ricerca - Università degli Studi di Pavia

Valsartan addition to amlodipine is more effective than losartan addition in hypertensive  patients inadequately controlled by amlodipine.

Amlodipine and valsartan: calcium channel blockers/angiotensin II receptor blockers combination for hypertension.

Amlodipine/valsartan: fixed-dose combination in hypertension.

Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists. Hypertension.

Angiotensin II receptor pharmacology and AT1-receptor blockers. J Hum Hypertens.

Beyond trough:peak ratio. A new index of the smoothness of the antihypertensive effect of a drug.

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until

Circulation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects. J Hypertens.

Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med.

Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker. J Clin Hypertens (Greenwich).

Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:

Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients.

Effects of different blood-pressure lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Efficacy and safety of losartanamlodipine combination – an Indian postmarketing surveillance experience.

Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study. J Clin Hypertens

for the Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients.

for the HOT study group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial.

for the Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology.

for the Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality. A meta analysis of individual data for one million adults in 61 prospective studies.

for the VALUE trial Group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or anlodipine:the value randomised trial.

Guidelines for 24 hour non invasive ambulatory blood pressure monitoring: report from a working group of the Italian Society of Hypertension.

Implications of the INTERALSALT.

of Hypertension-European Society of Cardiology Guidelines Committee.

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials.

Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.

Rationale for fixed dose combinations in the treatment of hypertension: the cycle repeats.

The “LOTHAR” study: evaluation of efficacy and tolerability of the fixed combination of amlodipine and losartan in the treatment of essential hypertension. Arq Bras Cardiol.

The role of combination therapy in the treatment of hypertension. Am J Hypertens.

The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2835558

Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine

Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine

Abstract

Similar works

Full text

Available Versions

Archivio Istituzionale della Ricerca - Università degli Studi di Pavia